Adverum Biotechnologies, Inc.
ADVMDelisted Dec 9, 2025- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001501756
Adverum Biotechnologies, Inc. was delisted on Dec 9, 2025; its insiders filed their last Form 4 on Dec 10, 2025; 50 institutions reported holding it in 13F filings for Q3 2025, worth $63.8M in total; no superinvestor held it.
13F holders, Q1 2024
Institutional positions in Adverum Biotechnologies, Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 61
- 0 vs. Q4 2023
- Shares held
- 16.8M
- +10.3M (+161.3%) vs. Q4 2023Converted for a 1-for-10 split
- Total value
- $236.9M
- +$188.6M (+390.8%) vs. Q4 2023
- New holders
- 23
- 21 more added
- Sold out
- 23
- 12 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ADVM on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 0 | $0 |
| Q1 2026 | 0 | $0 |
| Q4 2025 | 0 | $0 |
| Q3 2025 | 50 | $63.8M |
| Q2 2025 | 59 | $30.1M |
| Q1 2025 | 71 | $69.8M |
| Q4 2024 | 70 | $74.1M |
| Q3 2024 | 77 | $120.2M |
| Q2 2024 | 68 | $117.7M |
| Q1 2024 | 61 | $236.9M |
| Q4 2023 | 61 | $48.3M |
| Q3 2023 | 61 | $97.9M |
| Q2 2023 | 58 | $104.4M |
| Q1 2023 | 55 | $45.0M |
| Q4 2022 | 59 | $33.2M |
| Q3 2022 | 78 | $55.6M |
| Q2 2022 | 77 | $70.0M |
| Q1 2022 | 92 | $82.4M |
| Q4 2021 | 98 | $115.5M |
| Q3 2021 | 110 | $151.2M |
| Q2 2021 | 118 | $280.4M |
| Q1 2021 | 132 | $937.9M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Adverum Biotechnologies, Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 11 | $0 | 0.00% | +5+77.4% | AddedConverted for a 1-for-10 split |
| Deutsche Bank AG | 2 | $28 | 0.00% | +0+11.1% | AddedConverted for a 1-for-10 split |
| Allworth Financial LP | 2 | $29 | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Macquarie Group Ltd | 2,586 | $37 | 0.00% | +2,586 | New |
| GHP Investment Advisors, Inc. | 20 | $283 | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| JPMorgan Chase & Co | 38 | $537 | 0.00% | −3−6.2% | ReducedConverted for a 1-for-10 split |
| Parallel Advisors, LLC | 50 | $707 | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Wells Fargo & Company | 142 | $2.01K | 0.00% | +44+45.5% | AddedConverted for a 1-for-10 split |
| Rhumbline Advisers | 293 | $4.14K | 0.00% | 00.0% | UnchangedConverted for a 1-for-10 split |
| Lazard Asset Management LLC | 700 | $9.00K | 0.00% | −293−29.5% | ReducedConverted for a 1-for-10 split |
| UBS Group AG | 932 | $13.2K | 0.00% | +851+1,043.6% | AddedConverted for a 1-for-10 split |
| Tower Research Capital LLC (TRC) | 1,003 | $14.2K | 0.00% | +934+1,351.5% | AddedConverted for a 1-for-10 split |
| Advisor Group Holdings, Inc. | 2,050 | $29.0K | 0.00% | −8,000−79.6% | ReducedConverted for a 1-for-10 split |
| ADAR1 Capital Management, LLC | 2,800 | $39.6K | 0.01% | +2,800 | New |
| Acadian Asset Management LLC | 2,902 | $41.0K | 0.00% | +109+3.9% | AddedConverted for a 1-for-10 split |
| Northwest & Ethical Investments L.P. | 3,390 | $47.9K | 0.00% | +3,390 | New |
| Cubist Systematic Strategies, LLC | 8,483 | $119.9K | 0.00% | +8,483 | New |
| Group One Trading, L.P. | 9,250 | $130.8K | 0.00% | +7,619+467.2% | AddedConverted for a 1-for-10 split |
| Point72 Asia (Singapore) Pte. Ltd. | 9,276 | $131.2K | 0.03% | +9,276 | New |
| Charles Schwab Investment Management Inc | 10,713 | $151.5K | 0.00% | +7,072+194.2% | AddedConverted for a 1-for-10 split |
| Two Sigma Investments, LP | 11,842 | $167.4K | 0.00% | −32,798−73.5% | ReducedConverted for a 1-for-10 split |
| Balyasny Asset Management LLC | 14,198 | $200.8K | 0.00% | +14,198 | New |
| Cantor Fitzgerald, L. P. | 15,446 | $218.4K | 0.05% | −370−2.3% | ReducedConverted for a 1-for-10 split |
| Two Sigma Advisers, LP | 16,170 | $228.6K | 0.00% | −30,060−65.0% | ReducedConverted for a 1-for-10 split |
| Walleye Capital LLC | 16,369 | $231.5K | 0.00% | +16,369 | New |
| Shay Capital LLC | 23,395 | $330.8K | 0.10% | +23,395 | New |
| Dimensional Fund Advisors LP | 26,543 | $375.3K | 0.00% | +7,684+40.7% | AddedConverted for a 1-for-10 split |
| Quinn Opportunity Partners LLC | 26,829 | $379.4K | 0.04% | −13,001−32.6% | ReducedConverted for a 1-for-10 split |
| Squarepoint Ops LLC | 27,170 | $384.2K | 0.00% | +22,937+541.8% | AddedConverted for a 1-for-10 split |
| Marathon Trading Investment Management LLC | 28,340 | $400.7K | 0.16% | +28,340 | New |
| Northern Trust Corp | 36,740 | $519.5K | 0.00% | +18,705+103.7% | AddedConverted for a 1-for-10 split |
| Qube Research & Technologies Ltd | 41,619 | $588.5K | 0.00% | +41,547+57,946.0% | AddedConverted for a 1-for-10 split |
| Newtyn Management, LLC | 46,189 | $653.1K | 0.13% | −36,121−43.9% | ReducedConverted for a 1-for-10 split |
| Citigroup Inc | 52,605 | $743.8K | 0.00% | +52,605 | New |
| Barclays PLC | 53,258 | $753.1K | 0.00% | +53,258 | New |
| State Street Corp | 64,724 | $915.2K | 0.00% | +31,709+96.0% | AddedConverted for a 1-for-10 split |
| Picton Mahoney Asset Management | 123,966 | $1.75M | 0.07% | +123,966 | New |
| Renaissance Technologies LLC | 133,088 | $1.88M | 0.00% | −54,677−29.1% | ReducedConverted for a 1-for-10 split |
| Marshall Wace, LLP | 133,851 | $1.89M | 0.00% | +133,851 | New |
| AIGH Capital Management LLC | 162,547 | $2.30M | 1.11% | −154,735−48.8% | ReducedConverted for a 1-for-10 split |
| Bank of America Corp | 165,495 | $2.34M | 0.00% | −264,507−61.5% | ReducedConverted for a 1-for-10 split |
| Geode Capital Management, LLC | 193,516 | $2.74M | 0.00% | +107,095+123.9% | AddedConverted for a 1-for-10 split |
| Millennium Management LLC | 248,642 | $3.52M | 0.00% | +218,848+734.5% | AddedConverted for a 1-for-10 split |
| Samsara BioCapital, LLC | 291,666 | $4.12M | 0.64% | +291,666 | New |
| BlackRock Inc. | 316,450 | $4.47M | 0.00% | +176,332+125.8% | AddedConverted for a 1-for-10 split |
| Assenagon Asset Management S.A. | 358,719 | $5.07M | 0.01% | +358,719 | New |
| Avoro Capital Advisors LLC | 416,666 | $5.89M | 0.07% | +416,666 | New |
| Laurion Capital Management LP | 438,935 | $6.21M | 0.17% | +438,935 | New |
| Versant Venture Management, LLC | 506,822 | $7.17M | 6.95% | 00.0% | UnchangedConverted for a 1-for-10 split |
| 5AM Venture Management, LLC | 541,666 | $7.66M | 1.71% | +541,666 | New |
| Morgan Stanley | 562,035 | $7.95M | 0.00% | +46,995+9.1% | AddedConverted for a 1-for-10 split |
| Commodore Capital LP | 657,333 | $9.29M | 0.62% | −342,667−34.3% | ReducedConverted for a 1-for-10 split |
| Franklin Resources Inc | 675,675 | $9.55M | 0.00% | +675,675 | New |
| BML Capital Management, LLC | 833,117 | $11.8M | 7.89% | +377,692+82.9% | AddedConverted for a 1-for-10 split |
| FMR LLC | 900,527 | $12.7M | 0.00% | +288,100+47.0% | AddedConverted for a 1-for-10 split |
| Vanguard Group Inc | 907,151 | $12.8M | 0.00% | +488,248+116.6% | AddedConverted for a 1-for-10 split |
| Frazier Life Sciences Management, L.P. | 1,069,244 | $15.1M | 0.64% | +1,069,244 | New |
| Logos Global Management LP | 1,499,999 | $21.2M | 2.23% | +1,499,999 | New |
| Vivo Capital, LLC | 1,500,000 | $21.2M | 1.67% | +1,500,000 | New |
| VR Adviser, LLC | 1,556,419 | $22.0M | 1.05% | +1,041,664+202.4% | AddedConverted for a 1-for-10 split |
| TCG Crossover Management, LLC | 2,008,340 | $28.4M | 2.25% | +2,008,340 | New |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −455,279−100.0% | Sold outConverted for a 1-for-10 split |
| Sonic GP LLC | 0 | $0 | 0.00% | −200,000−100.0% | Sold outConverted for a 1-for-10 split |
| Worth Venture Partners, LLC | 0 | $0 | 0.00% | −78,435−100.0% | Sold outConverted for a 1-for-10 split |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −42,500−100.0% | Sold outConverted for a 1-for-10 split |
| Acuitas Investments, LLC | 0 | $0 | 0.00% | −29,125−100.0% | Sold outConverted for a 1-for-10 split |
| Susquehanna International Group, LLP | 0 | $0 | 0.00% | −19,587−100.0% | Sold outConverted for a 1-for-10 split |
| Monaco Asset Management SAM | 0 | $0 | 0.00% | −7,923−100.0% | Sold outConverted for a 1-for-10 split |
| Jefferies Financial Group Inc. | 0 | $0 | 0.00% | −7,500−100.0% | Sold outConverted for a 1-for-10 split |
| Marquette Asset Management, LLC | 0 | $0 | 0.00% | −6,012−100.0% | Sold outConverted for a 1-for-10 split |
| Apexium Financial, LP | 0 | $0 | 0.00% | −6,000−100.0% | Sold outConverted for a 1-for-10 split |
| XTX Topco Ltd | 0 | $0 | 0.00% | −5,110−100.0% | Sold outConverted for a 1-for-10 split |
| Mariner, LLC | 0 | $0 | 0.00% | −5,000−100.0% | Sold outConverted for a 1-for-10 split |
| Bank of New York Mellon Corp | 0 | $0 | 0.00% | −3,961−100.0% | Sold outConverted for a 1-for-10 split |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −3,371−100.0% | Sold outConverted for a 1-for-10 split |
| Lipe & Dalton | 0 | $0 | 0.00% | −1,500−100.0% | Sold outConverted for a 1-for-10 split |
| American Century Companies Inc | 0 | $0 | 0.00% | −1,306−100.0% | Sold outConverted for a 1-for-10 split |
| IPG Investment Advisors LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold outConverted for a 1-for-10 split |
| Nwam LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold outConverted for a 1-for-10 split |
| Ausdal Financial Partners, Inc. | 0 | $0 | 0.00% | −1,000−100.0% | Sold outConverted for a 1-for-10 split |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −233−100.0% | Sold outConverted for a 1-for-10 split |
| Northwestern Mutual Wealth Management Co | 0 | $0 | 0.00% | −95−100.0% | Sold outConverted for a 1-for-10 split |
| Sound Income Strategies, LLC | 0 | $0 | 0.00% | −1−100.0% | Sold outConverted for a 1-for-10 split |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −0−100.0% | Sold outConverted for a 1-for-10 split |